Human Anti-ZIKV NS1(Zika Virus Non-structural Protein) IgG ELSIA Kit

The Zika virus (ZIKV) is a mosquito-borne virus that belongs to the Flavivirus genus and family. The ZIKV has spread widely over Africa and Asia, causing multiple epidemics since its discovery in Uganda's Zika Forest in 1947. The 2015 Brazilian outbreak drew international attention since it was associated with significant illnesses such as adult Guillain-Barré syndrome (GBS) and baby microcephaly. The Flavivirus family includes several viruses that pose a major hazard to public health, such as the Japanese encephalitis virus (JEV), West Nile virus (WNV), Dengue virus (DENV), and yellow fever virus (YFV). The ZIKV consists of three proteins: an envelope (E), a membrane (M), and a core (C). The genome is a single-stranded positive-sense RNA that encodes three structural proteins (C, prM, and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). ZIKV is typically transmitted to people through mosquito bites from Aedes aegypti or Aedes albopictus, but it can also be transmitted through sexual contact and from mother to child. Despite global research into ZIKV, there is currently no effective vaccine or therapy. The epidemiological characteristics of ZIKV have shifted substantially in recent decades. ZIKV was once assumed to be a small mosquito-borne virus with minor symptoms. However, the widespread outbreak in 2015 also found a connection between ZIKV and neurological conditions like Guillain-Barré syndrome and severe birth defects. This finding caused the World Health Organization (WHO) to proclaim the ZIKV outbreak a Public Health Emergency of International Concern.

The NS1 protein is an essential non-structural protein in the Flavivirus family, with many roles in the viral lifecycle. NS1 has a molecular weight of approximately 46 kDa and consists of 352 amino acids. It has three structural domains: the N-terminal β-roll domain (residues 1-29), the wing domain (residues 30-180), and the β-strand domain (residues 181-352). This protein exists in three forms: monomeric in the cytoplasm, membrane-associated dimer (mNS1), and secreted hexamer. In the early phases of viral replication, NS1 functions as a dimer and is secreted into infected people's blood as a hexamer. NS1's strong immunogenicity makes it an important marker for early detection of viral infection. It activates not just the complement system and immune cells, but also endothelial cells, causing endothelial dysfunction and aiding viral dissemination. Furthermore, NS1 is strongly linked to the severity of Flavivirus infections, and in ZIKV infections, NS1 is thought to be linked to placental dysfunction. NS1 may influence prenatal brain development by regulating placental function, which could contribute to neonatal microcephaly.

Figure 1. Current Perspectives on NS1 Secretion and Transport Pathways (Source: Chew BLA, et al., 2024)

Currently, ZIKV infection is diagnosed mostly using PCR testing and serological assays. The great similarity of NS1 proteins among Flavivirus family members makes it difficult to recognize specific viruses. To improve ZIKV detection specificity, unique monoclonal antibodies targeting ZIKV NS1 are being developed, with ongoing research into their potential for detecting and treating acute infections. For example, the high content of released NS1 (sNS1) in the blood of infected patients makes it a useful diagnostic for diagnosing acute infections. Furthermore, NS1 plays an important role in vaccine development and antibody treatments, with antibodies targeting NS1 offering effective protection and inhibiting ZIKV in both in vitro and in vivo studies. High-resolution structural maps of NS1 in association with human antibodies were created using cryo-electron microscopy and other structural biology techniques, showing epitope recognition and antibody protection mechanisms. These findings provide an important theoretical and practical foundation for developing NS1-based vaccines and treatment methods. In conclusion, research on ZIKV and its NS1 protein not only explains the virus's structure and function but also provides significant knowledge for building novel diagnostic tools and treatment options. With a better understanding of the roles and structures of the NS1 protein, more effective vaccines and therapies may emerge in the future, providing new hope for controlling ZIKV and related disorders.

Zika Virus NS1 IgG ELISA Kit
Anti-Zika Virus NS1 IgG Detection Kit
ZIKV NS1 IgG Enzyme-Linked Immunosorbent Assay Kit